Synthesis, characterization and antimycobacterial activity of Ag(I)-aspartame, Ag(I)-saccharin and Ag(I)-cyclamate complexes

Archiv der Pharmazie

Volumn 340, Issue 10, 2007, Pages 538-542

  Cavicchioli, Maurício ^a   Leite, Clarice Q F ^a   Sato, Daisy N ^b   Massabni, Antonio C ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

Author keywords

Antimycobacterial activity; MABA; Silver aspartame; Silver cyclamate; Silver saccharin

Indexed keywords

ASPARTAME; CYCLAMATE SODIUM; SACCHARIN; SILVER DERIVATIVE;

ARTICLE; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIA KANSASII; MYCOBACTERIUM AVIUM; MYCOBACTERIUM INTRACELLULARE; MYCOBACTERIUM MALMOENSE; MYCOBACTERIUM TUBERCULOSIS; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS;

ANTI-BACTERIAL AGENTS; ASPARTAME; CYCLAMATES; HUMANS; LIGANDS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIA, ATYPICAL; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; ORGANOMETALLIC COMPOUNDS; SACCHARIN; SILVER;

EID: 35548935222     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200700040     Document Type: Article

References (28)

1. WHO (World Health Organization), Report 2007, Geneva (WHO/HTM/TB/2007. 376).
2. R. F. Cardoso, R. C. Cooksey, G. P. Morlock, P. Barco, et al., Antimicrob. Agents Chemother. 2004, 48, 3373-3381.
3. C. Dye, M. A. Espinal, C. J. Watt, C. Mbiaga, B. G. William, Infect. Dis. 2002, 185, 1197-1202.
4. S. Silver, FEMS Microbiol. Rev. 2003, 27, 341-353.
5. M. J. M. Vaerewijck, G. Huys, J. C. Palomino, J. Swings, F. Portaels, FEMS Microbiol. Rev. 2005, 29, 911-934.
6. S. J. Berners-Price, R. K. Johnson, A. J. Giovenella, L. F. Faucette, et al., J. Inorg. Biochem. 1988, 33, 285-295.
7. G. G. de Gracia, Burns 2001, 27, 67-74.
8. H. J. Klasen, Burns 2000, 26, 117-130.
9. K. Nomiya, H. Yokohama, J. Chem. Soc. Dalton Trans. 2002, 12, 2483-2490.
10. K. Nomiya, Y. Kondoh, K. Onoue, N. C. Kasuga, et al., J. Inorg. Biochem. 1995, 58, 255-267.
11. H. J. Klasen, Burns 2000, 26, 131-138.
12. Y. Matsui, K. Otomo, S. Ishida, K. Yanagihara, et al., Microbiol. Immunol. 2004, 48, 489-495.
13. R. B. Thurman, C. P. Gerba, Crit. Rev. Environm. Cont. 1988, 18, 295-315.
14. K. Nomiya, R. Noguchi, M. Oda, Inorg. Chim. Acta 2000, 298, 24-32.
15. K. Nomiya, R. Noguchi, T. Shigeta, Y. Kondoh, et al., Bull. Chem. Soc. Jpn. 2000, 73, 1143-1152.
16. M. Cavicchioli, L. C. Varanda, A. C. Massabni, P. Melnikov, Mater. Lett. 2005, 59, 3583-3589.
17. M. Cavicchioli, A. C. Massabni, A. M. C. Ferreira, E. E. Castellano, M. S. Crespi, Inorg. Chim. Acta 2005, 358, 4431-4436.
18. M. Cavicchioli, P. P. Corbi, A. C. Massabni, P. Melnikov, J. Coord. Chem. 2002, 55, 952-958.
19. P. P. Corbi, A. C. Massabni, A. G. Moreira, F. J. Medrano, et al., Can. J. Chem. 2005, 83, 104-109.
20. P. P. Corbi, A. C. Massabni, C. M. Costa Neto, J. Coord. Chem. 2005, 58, 1477-1483.
21. A. C. Massabni, P. P. Corbi, P. Melnikov, M. A. Zacharias, H. R. Rechenberg, J. Broz. Chem. Soc. 2005, 16, 718-722.
22. th Ed., John Wiley & Sons, New York, 1991, pp. 102-131.
23. R. Weber, M. Gilles, G. Bergerhoff, Z. Kristallographie 1993, 206, 273-274.
24. S. Hamamci, V. T. Yilmaz, W. T. A. Harrison, C. Thöne, Solid State Sciences 2005, 7, 423-329.
25. C. Q. F. Leite, S. R. A. N. Leite, M. H. F. Saad, Microbiol. Immunol. 2005, 49, 571-578.
26. P. T. Kent, C. Kubica, Eds. A guide for the level-III laboratory, Atlanta, GA, USA, Centers for Disease Control, 1985.
27. F. A. Castelo, A. L. Kritiski, A. W. Barreto, et al., J. Bras. Pneumol. 2004, 30, S24-S37.
28. L. A. Collins, S. G. Franzblau, Antimicrob. Agents Chemother. 1997, 41, 1004-1009.